01
Study-related assessments
Screening tests and study medicine may be provided at no charge when the protocol and site confirm coverage.
International patient recruitment
Explore eligible clinical trials in China with a clear next step
PatientChina helps overseas patients request a preliminary review, understand study requirements, and coordinate communication with licensed Chinese hospitals and research teams.
A clinical trial is a regulated research pathway. Eligibility, treatment, safety monitoring, and any reimbursement depend on the specific protocol and the physician’s assessment.
Protocol-based careStudy procedures follow an approved research protocol.
Hospital assessmentLicensed physicians decide whether a study may be appropriate.
International coordinationWe help with documents, communication, and next steps.
What participation may include
A structured route when standard options are limited
Some studies evaluate investigational medicines. Others examine approved medicines in new indications or settings. The protocol determines what is covered and how follow-up works.
02
Specialist follow-up
Participants are monitored by the research team according to the study schedule, with safety reporting and follow-up.
03
Participant support
Some studies offer participant reimbursement. The amount, timing, and eligibility are set by the study and should be confirmed in writing.
Hospital care settings. These photographs do not establish clinical trial availability or eligibility.
Current recruitment focus
Chronic disease, oncology, and blood disorders
The list below describes areas we may screen for. Open studies change over time, and every case must be checked against the current protocol.
Typical chronic disease profile
Recurring or difficult-to-control disease may be considered when a suitable study is open.
Chronic conditions
Oncology and blood disorders
Oncology situations we may screen
For example, newly diagnosed disease without a surgical option, or disease that has progressed or metastasized after systemic treatment. A study team must confirm the details.
Daily recruitment updates
Four study areas to review today
These are information leads for an initial conversation. Availability, eligibility, phase, visit schedule, and reimbursement must be confirmed by the research center.
Published: 26 Sep 2026 · Chronic disease
Recurrent small-cell lung cancer, Phase III
DS-7300a (I-DXd), a B7-H3 antibody drug conjugate, compared with physician choice. Registration: CTR20242805.
SCLC · CTR20242805Published: 26 Sep 2026 · Oncology
Cancer treatment-induced thrombocytopenia
Romiplostim N01 (QL0911), a randomized Phase II/III study with placebo control. Registration: CTR20242788.
CIT · CTR20242788Published: 26 Sep 2026 · Metabolic
Overweight and obesity, Phase Ib
TQF3250 oral capsule, a GLP-1 receptor agonist study for adults with overweight or obesity. Registration: CTR20263344.
Obesity · CTR20263344Published: 26 Sep 2026 · Blood disorders
HPV16/18-related CIN2/3, Phase I/II
RG002 therapeutic mRNA vaccine study for HPV16/18-related CIN2/3. Registration: CTR20251020.
CIN2/3 · CTR20251020Daily FAQ updates
Two patient questions answered today
Published: 26 Sep 2026 · FAQ
Is a clinical trial the same as guaranteed treatment?
No. A trial has defined criteria, and licensed physicians and the research center decide whether participation is appropriate.
Published: 26 Sep 2026 · FAQ
Are tests and study medicines free?
Some study-related costs may be covered by the sponsor under the protocol. The research site explains coverage before enrollment.
How it works
Four steps from records to a decision
We help you understand the pathway before you decide whether to travel or proceed.
STEP 01
Preliminary review
Send a concise medical summary and key reports. The initial review service is US$50.
STEP 02
Expert opinion
With your consent, provide detailed records for a physician’s written assessment. The report service is US$300.
STEP 03
Study matching
If a possible study is identified, the research center reviews eligibility, timing, and required visits.
STEP 04
Travel and follow-up
You decide whether to continue. Visits may take place several times or over up to a year, depending on the protocol.
Costs and responsibilities
Know what is covered before you commit
Study-related coverage is controlled by the sponsor and hospital protocol. Our coordination services and your international travel are separate.
PatientChina service
US$50
Initial review of the information you provide and an early indication of whether a current study may be worth discussing.
Expert written report
US$300
A physician’s written opinion based on detailed records, with a recommendation about whether to explore a clinical trial.
Please budget separately:flights, visa fees, accommodation, local transport, translation, and PatientChina coordination fees are paid by the patient unless confirmed otherwise in writing. No service guarantees enrollment or treatment outcome.
Questions patients ask
Clear answers before you send records
No. A trial is a regulated research pathway with defined inclusion and exclusion criteria. A licensed physician and the research center decide whether you can participate, and you may withdraw according to the consent process.
Some study-related tests and medicines may be covered by the sponsor under the protocol. The site will explain coverage, visit requirements, and any participant costs before enrollment.
Some studies evaluate an approved medicine for a new indication, dose, combination, or population. Whether that is possible depends on the specific study and physician assessment.
No. PatientChina is a medical consultation and patient coordination platform. We do not diagnose, prescribe, or make enrollment decisions. Those decisions belong to licensed physicians and research centers.
International patient support
Clear communication from consultation to care
Our coordination team helps international families communicate with hospital teams, understand next steps, and prepare the information needed for a review.
Connect with PatientChina
Scan the channel you use most. For medical records, please use the secure contact instructions we provide after your initial request.
Care in context
People, teams, and treatment settings
These photographs show the hospital environment and international patient coordination work. They are provided for general information and do not represent a guarantee of any individual outcome.
Contact the coordination team
Send your records by email or WhatsApp
Tell us your diagnosis, current treatment, and country of residence. We will reply with the information needed for an initial review. Please remove sensitive identifiers from documents unless they are necessary for medical assessment.
What to include
- Full name and current country
- Diagnosis and date of diagnosis
- Current treatment and recent changes
- Key reports, pathology, imaging, or laboratory results
- Your preferred language and contact method
A message starts a coordination review. It does not guarantee study eligibility, enrollment, treatment, reimbursement, or outcome.